These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 7512002)

  • 1. Enzyme immunoassay of serum type IV collagen in anti-HCV positive chronic liver diseases.
    Matsuzaki Y; Yoshiga S; Sugitani T; Shoda J; Tanaka N; Osuga T
    Clin Chim Acta; 1993 Nov; 221(1-2):209-17. PubMed ID: 7512002
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of interferon therapy on fibrosis serum markers in HCV-positive chronic liver disease.
    Mazzoran L; Tamaro G; Mangiarotti MA; Marchi P; Baracetti S; Gerini U; Fanni-Cannelles M; Zorat F; Pozzato G
    Eur J Gastroenterol Hepatol; 1998 Feb; 10(2):125-31. PubMed ID: 9581987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum hyaluronate predicts response to interferon-alpha therapy in patients with chronic hepatitis C.
    Ueno T; Inuzuka S; Sata M; Koh H; Tamaki S; Kin M; Sugawara H; Sakata R; Torimura T; Tanikawa K
    Hepatogastroenterology; 1995; 42(5):522-7. PubMed ID: 8751209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Managing chronic hepatitis C virus infection.
    Lau JY; Davis GL
    BMJ; 1993 Feb; 306(6876):469-70. PubMed ID: 7680588
    [No Abstract]   [Full Text] [Related]  

  • 5. Concentration of serum laminin and type IV collagen in liver diseases assayed by a sandwich enzyme-immunoassay using monoclonal antibodies.
    Yokoya Y; Iwata K; Muragaki Y; Shiota C; Morimoto Y; Inoue M; Itoh H; Nishioka S; Ooshima A
    Clin Chim Acta; 1992 Sep; 210(1-2):109-18. PubMed ID: 1330375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies to non-structural hepatitis C virus antigens: a link with liver disease activity?
    Gessoni G; Manoni F
    Eur J Med; 1992 Sep; 1(5):288-94. PubMed ID: 1285245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus in patients with acute and chronic liver disease.
    Mehta SK; Singh V; Bhasin DK; Kumar YR; Kochhar R
    Indian J Gastroenterol; 1992 Jul; 11(3):146. PubMed ID: 1380490
    [No Abstract]   [Full Text] [Related]  

  • 8. Molecular typing of hepatitis C virus genome from sera and liver tissues of patients with anti-HCV positive chronic liver disease.
    Yoon SK; Park YM; Chung KW; Kim BS; Kim CJ; Kim WY; Chang SK; Cho MJ
    Korean J Intern Med; 1993 Jul; 8(2):66-72. PubMed ID: 7518242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitivity of second generation anti-HCV test for diagnosis of acute hepatitis C.
    Frösner GG
    Infection; 1991; 19(6):434. PubMed ID: 1726167
    [No Abstract]   [Full Text] [Related]  

  • 10. Significance of serum type-IV collagen levels in various liver diseases. Measurement with a one-step sandwich enzyme immunoassay using monoclonal antibodies with specificity for pepsin-solubilized type-IV collagen.
    Ueno T; Inuzuka S; Torimura T; Oohira H; Ko H; Obata K; Sata M; Yoshida H; Tanikawa K
    Scand J Gastroenterol; 1992 Jun; 27(6):513-20. PubMed ID: 1631498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of anti-HCV in cryptogenic cirrhosis in a suburban Detroit community.
    Barnes RE; Meyer RA; Gordon SC
    Am J Gastroenterol; 1992 Aug; 87(8):1001-4. PubMed ID: 1379412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-HCV-positive cirrhosis associated with schistosomiasis.
    Koshy A; al-Nakib B; al-Mufti S; Madda JP; Hira PR
    Am J Gastroenterol; 1993 Sep; 88(9):1428-31. PubMed ID: 7689784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of antibodies to hepatitis C virus among Saudi patients with chronic liver diseases.
    Ayoola EA; al-Mofleh IA; al-Faleh FZ; al-Rashed R; Arif MA; Ramia S; Mayet I
    Hepatogastroenterology; 1992 Aug; 39(4):337-9. PubMed ID: 1385286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevalence of antibodies against hepatitis C virus (anti HCV) in different populations with chronic liver disease using the first generation test].
    Findor JA; Silva M; Medina M; Bruch Igartúa E; Sordá J; Findor AJ; Schiff E
    Acta Gastroenterol Latinoam; 1991; 21(4):221-5. PubMed ID: 1668600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus infection in chronic liver disease in Somalia.
    Aceti A; Taliani G; Bruni R; Sharif OS; Moallin KA; Celestino D; Quaranta G; Sebastiani A
    Am J Trop Med Hyg; 1993 Apr; 48(4):581-4. PubMed ID: 7683179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of antibody to hepatitis C virus (anti-HCV) in chronic liver diseases (CLD) in southern Italy.
    Amitrano L; Ascione A; Canestrini C; D'Agostino S; Iaccarino L; Vacca C; Gigliotti T
    Ital J Gastroenterol; 1990 Feb; 22(1):16-8. PubMed ID: 1966702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hepatitis C virus in chronic hepatitis and liver cirrhosis].
    Yamada G; Endo H; Takahashi M; Tsuji T
    Nihon Rinsho; 1991 Feb; 49(2):426-31. PubMed ID: 1849204
    [No Abstract]   [Full Text] [Related]  

  • 18. Hepatitis C virus antibodies in patients with chronic liver disease: ELISA and RIBA HCV strip immunoblot assay results.
    Baskin G; DiNello R; Polito A; Quan S; Lee WS; Wu J; Nelles M; Lee S
    Gut; 1993; 34(2 Suppl):S61. PubMed ID: 7686119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody to hepatitis C virus in patients with chronic schistosomiasis.
    Uemura K; Kawaguchi T; Sodeyama T; Kiyosawa K
    Ann Trop Med Parasitol; 1992 Jun; 86(3):257-62. PubMed ID: 1333179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody response to hepatitis C virus infection after liver transplantation.
    Hsu HH; Wright TL; Tsao SC; Combs C; Donets M; Feinstone SM; Greenberg HB
    Am J Gastroenterol; 1994 Aug; 89(8):1169-74. PubMed ID: 7519818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.